Medicinal marijuana player MGC Pharmaceuticals are on a mission to be one of the first ASX listed companies to garner serious revenues from medicinal cannabis derived products. The company announced this week they had signed up wholesalers in Europe to market their cannabis derived skin care and cosmetics lines.
02/05/2017 - 13:57
MGC Pharma signs new cannabis cosmetics wholesalers in Europe
By Matt Birney
02/05/2017 - 13:57
Related Data & Insights
-
-
Rank Company Revenue 151st 8I Holdings $1.8m 152nd Norwood Systems $1.7m 153rd Argent BioPharma $1.7m 154th AusCann Group Holdings $1.7m 155th Skin Elements $1.6m 198 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
07 Jun 2023
Board Moves May 31 to June 2, 2023
01 Mar 2023
Board Moves March 1, 2023
03 Jan 2023
Board Moves January 3, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX